Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine

Clinical and Vaccine Immunology

Volumn 17, Issue 7, 2010, Pages 1104-1110

  Foster, Rachel A ^a   Carlring, Jennifer ^a   Lees, Andrew ^b   Borrow, Ray ^c   Ramsay, Mary ^c   Kacsmarski, Ed ^c   Miller, Elizabeth ^c   McKendrick, Michael W ^d   Heath, Andrew W ^a   Read, Robert C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Fina Biosolutions LLC   (United States)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; DEXTRAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MENINGOCOCCUS VACCINE; SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; FEMALE; FUNCTIONAL T LYMPHOCYTE DEFICIENCY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOREACTIVITY; INFECTION PREVENTION; INFECTION RESISTANCE; LYMPHOCYTE PROLIFERATION; MALE; MENINGOCOCCOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT FAILURE; VACCINATION; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; EPIDEMIC MENINGITIS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; PATHOLOGY; T LYMPHOCYTE;

ADOLESCENT; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; LYMPHOCYTE ACTIVATION; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; T-LYMPHOCYTES; TREATMENT FAILURE;

EID: 77954370182     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00481-09     Document Type: Article

References (21)

1. Auckland, C., S. Gray, R. Borrow, N. Andrews, D. Goldblatt, M. Ramsay, and E. Miller. 2006. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J. Infect. Dis. 194:1745-1752.
2. Balmer, P., R. Borrow, and E. Miller. 2002. Impact of meningococcal C conjugate vaccine in the UK. J. Med. Microbiol. 51:717-722.
3. Blanchard Rohner, G., M. D. Snape, D. F. Kelly, T. John, A. Morant, L. M. Yu, A. Borkowski, F. Ceddia, R. Borrow, C. A. Siegrist, and A. J. Pollard. 2008. The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response. J. Immunol. 180:2165-2173.
4. Borrow, R., P. Balmer, and E. Miller. 2005. Meningococcal surrogates of protection - serum bactericidal antibody activity. Vaccine 23:2222-2227. (Pubitemid 40341456)
5. Borrow, R., P. Balmer, and M. H. Roper. 2007. The immunological basis for immunization series, module 3: tetanus (update 2006). World Health Organization, Geneva, Switzerland.
6. Breukels, M. A., E. Jol-van der Zijde, M. J. van Tol, and G. T. Rijkers. 2002. Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed. Clin. Infect. Dis. 34:191-197.
7. Cartwright, K. A., J. M. Stuart, D. M. Jones, and N. D. Noah. 1987. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol. Infect. 99:591-601.
8. Chen, Q., J. L. Cannons, J. C. Paton, H. Akiba, P. L. Schwartzberg, and C. M. Snapper. 2008. A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T-cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine. J. Immunol. 181:8258-8266.
9. Foster, R. A., J. Carlring, M. W. McKendrick, A. Lees, R. Borrow, R. C. Read, and A. W. Heath. 2009. Evidence of a functional B-cell immunodefi- ciency in adults who experience serogroup C meningococcal disease. Clin. Vaccine Immunol. 16:692-698.
10. Goldblatt, D. 2000. Conjugate vaccines. Clin. Exp. Immunol. 119:1-3.
11. + T cell help. J. Immunol. 172:532-539.
12. Lal, G., P. Balmer, H. Joseph, M. Dawson, and R. Borrow. 2004. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135. Clin. Diagn. Lab. Immunol. 11:272-279.
13. Lal, G., P. Balmer, E. Stanford, S. Martin, R. Warrington, and R. Borrow. 2005. Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J. Immunol. Methods 296:135-147. (Pubitemid 40174747)
14. Lee, Y. C., D. F. Kelly, L. M. Yu, M. P. Slack, R. Booy, P. T. Heath, C. A. Siegrist, R. E. Moxon, and A. J. Pollard. 2008. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin. Infect. Dis. 46:186-192.
15. Maiden, M. C., A. B. Ibarz-Pavon, R. Urwin, S. J. Gray, N. J. Andrews, S. C. Clarke, A. M. Walker, M. R. Evans, J. S. Kroll, K. R. Neal, D. A. Ala'aldeen, D. W. Crook, K. Cann, S. Harrison, R. Cunningham, D. Baxter, E. Kaczmarski, J. Maclennan, J. C. Cameron, and J. M. Stuart. 2008. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J. Infect. Dis. 197:737-743.
16. Maslanka, S. E., L. L. Gheesling, D. E. Libutti, K. B. Donaldson, H. S. Harakeh, J. K. Dykes, F. F. Arhin, S. J. Devi, C. E. Frasch, J. C. Huang, P. Kriz-Kuzemenska, R. D. Lemmon, M. Lorange, C. C. Peeters, S. Quataert, J. Y. Tai, and G. M. Carlone. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin. Diagn. Lab. Immunol. 4:156-167.
17. Pecanha, L. M., C. M. Snapper, F. D. Finkelman, and J. J. Mond. 1991. Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. J. Immunol. 146:833-839.
18. Pickering, J. W., T. B. Martins, M. C. Schroder, and H. R. Hill. 2002. Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for quantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae type b. Clin. Diagn. Lab. Immunol. 9:872-876.
19. Robinson, K., K. R. Neal, C. Howard, J. Stockton, K. Atkinson, E. Scarth, J. Moran, A. Robins, I. Todd, E. Kaczmarski, S. Gray, I. Muscat, R. Slack, and D. A. Ala'Aldeen. 2002. Characterization of humoral and cellular immune responses elicited by meningococcal carriage. Infect. Immun. 70:1301-1309.
20. Trotter, C. L., N. J. Andrews, E. B. Kaczmarski, E. Miller, and M. E. Ramsay. 2004. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364:365-367. (Pubitemid 38970013)
21. Trotter, C. L., and M. E. Ramsay. 2007. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiol. Rev. 31:101-107.